Amylin and selective glucoregulatory peptide alterations during prolonged exercise.
Amylin is a pancreatic β-cell peptide that facilitates the regulation of blood glucose concentration by inhibiting release of glucagon and modulating gastric emptying. Prolonged exercise may alter amylin and aid in the maintenance of blood glucose concentration; however, no studies have investigated the effects of prolonged exercise on amylin.


OBJECTIVE
This study aimed to determine the effects of 90 min of treadmill exercise on amylin and other glucoregulatory hormone responses in a postprandial state.


METHODS
Eight young healthy males completed a preliminary trial for VO2max and body composition determination and subsequent experimental and control trials in a counterbalanced manner. The experimental trial subjects arrived at the laboratory at 8:00 a.m., 1 h after consumption of a standard nutrient beverage (Ensure Plus®). At 9:50 a.m., subjects initiated 90 min of treadmill exercise at 60% of VO2max. Blood samples were collected twice before exercise, every 18 min during exercise, and every 20 min during 1 h of recovery. A resting control trial was conducted in an identical manner without VO2 assessment.


RESULTS
Plasma glucose and leptin concentrations remained stable across exercise, whereas lactate significantly increased to peak at 18 min of exercise then gradually declined. Amylin, insulin, and C-peptide values significantly declined over the trials, with no difference between exercise and control days. Glucagon area-under-the-curve concentrations were significantly greater during the exercise than the control trials. There was a significant time effect and trial effect for cortisol with a higher concentration during the experimental trial than during the control trial.


CONCLUSIONS
In a postprandial state, prolonged exercise stimulates glucagon and cortisol increases that are associated with stable blood glucose and leptin concentrations; however, similar to postprandial state control condition, insulin, C-peptide, and amylin concentrations decline.
Department of Kinesiology and Health Studies, Southeastern Louisiana University, Hammond, LA, USA. rkraemer@selu.edu
Robert R
RR
Kraemer
Michelle R
MR
Francois
Kiran
K
Sehgal
Bovorn
B
Sirikul
Roldán A
RA
Valverde
V Daniel
VD
Castracane
D000328:Adult; D001786:Blood Glucose / Q000502:physiology; D002096:C-Peptide / Q000097:blood; D015444:Exercise / Q000502:physiology*; D005934:Glucagon / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007328:Insulin / Q000097:blood; D058228:Islet Amyloid Polypeptide / Q000097:blood*; D019344:Lactic Acid / Q000097:blood; D020738:Leptin / Q000097:blood; D008297:Male; D010101:Oxygen Consumption / Q000502:physiology; D019518:Postprandial Period / Q000502:physiology; D055815:Young Adult
D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D020738:Leptin; D019344:Lactic Acid; D005934:Glucagon; D006854:Hydrocortisone